ArticleOpen forum infectious diseases2022

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection.

Jeremy J Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.